ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
| 3.61 Delayed Data As of Jan 22 |  +0.01 / +0.28%Today’s Change | 1.80 Today|||52-Week Range 4.54 | +43.25% Year-to-Date |
Latest ZIOP News | Press Releases
No recent news for ZIOPHARM Oncology Inc.
Today’s Trading
| Previous close | 3.60 |
| Today’s open | 3.51 |
| Day’s range | 3.43 - 3.64 |
| Volume | 99,350 |
| Average volume (3 months) | 1,899,719 |
| Market cap | $775.7M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -43.55% |
| Earnings growth (this year) | +46.96% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VXRTVaxart Inc | +0.13 | +1.87% |
| PRVLPrevail Therapeutics... | 0.00 | 0.00% |
| RUBYRubius Therapeutics ... | +0.25 | +2.71% |
| SYRSSyros Pharmaceutical... | -0.06 | -0.49% |
Data as of 7:16pm ET, 01/22/2021
Financials
| Next reporting date | March 4, 2021 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$117.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
